chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No adverse effect reported; patient was inadvertently administered a dose of PROQUAD, instead of a dose o MMR II and Varivax; unspecified 18 year old patient was inadvertently administered a dose of PROQUAD, instead of a dose o MMR II and Varivax; This spontaneous report has been received from a medical assistant , concerning a 18 year old non-pregnant female patient with no allergies, drug reactions, concurrent conditions or pertinent medical history reported. There were no concomitant medications.  On 26-JUN-2019, the patient was inadvertently vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) albumin status rha, lot # R020675 with expiration date 15-JAN-2020, subcutaneously (dose and frequency were not provided) for prophylaxis instead of a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) and varicella virus vaccine live (oka/merck)(VARIVAX). No adverse effects were reported.
Patient returned to clinic on Friday 4/2/18. Patient states following injection she had temperature of 102 F for which she has been taking ADVIL and TYLENOL alternating every 4 hours. She stated she has pain in left arm since injection. Patient states last dose was 0400 of 400mg ADVIL (patient didn't eat with dose). Patient states she suffered a single emesis approx. 10 minutes prior to arrival at clinic. Continues to have nausea. Patient guarding left arm use states it is very sensitive to touch. UE girth: L 12" r 10.5". Hives from deltoid descending down arm 4" x3". Patient denies shortness of breath. Had a single loose bowel movement since Wed. morning. Patient denies blood in stool. Patient states that Tues at 2300 she developed body pain and symptoms. She is scheduled to travel out of the country.
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age or gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On 11-MAY-2009, patient received improperly stored VARIVAX dose 1, from lot # 663710/0219Y expiry date: 13-FEB-2011. No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of the several reports received from the same reporter. Additional information has been requested.
2nd day: chills, fatigue, nausea, light headed, headache 3rd day: nausea, fatigue, light headed, headache
Vaccinating pharmacist was not informed by the LTCF that patient had already received second dose and administered another dose. No adverse reaction reported.
i am having a severe reactions to insect bites.  6+ inches of redness, followed by an open sore and finally scabbing over.  I have never had this extreme reaction before,   I have also had isolated muscle fatigue in just one area at a time.
full body hives lasted approx 30 days.  Treated with Hydroxyz hcl.   Numbness and tingling on back sides of tongue lasted approx 2 to 3 days
Flu like symptoms including fatigue, Body aches and headache started after 3 hours and stayed for 2 days.  Insomnia, Low fever and nausea were experienced periodically over two days.  Tylenol helped with headache and body aches and took it every 6 hours.
breaks on the field with heart problems; Initial information received on 27-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who experienced breaks on the field with heart problems while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for immunization.  On an unknown date the patient developed a non-serious event "breaks on the field with heart problems" (cardiac disorder) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "It goes on and on, and on.. it's happening everywhere, and is not normal. Breaks on the field with heart problems".  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (breaks on the field with heart problems).  At time of reporting, the outcome was Unknown for the event breaks on the field with heart problems.
This spontaneous report as received from a physician refers to a multiple, unspecified patients of unknown age and gender. There was no information about the patients concurrent conditions, concomitant therapies or medical history provided. On an unknown dates, the patients "might had been administered" an improperly stored dose of GARDASIL 9 (strength, dose, frequency, route of administration, lot # and expiration date were not reported). The storage temperature was 30 Fahrenheit degree for a 84 hours (7 cycles of 12 hours each cycle). There was an data logger. The products were back to range. No adverse effects were reported. Additional information has been requested.
rt arm very painful-shoulder to wrist; no swelling, no redness, no fever;
This spontaneous report as received from a Certified Medical Assistant refers to an unspecified number of patients of unknown age. On an unknown dates the patients were vaccinated with a improperly stored dose of GARDASIL (route, dose, strength, lot # and expiration date was not provided). No adverse effect reported. This is one of several reports from the same source. Additional information has been requested.
Small rash developed on left arm two days after receiving vaccine.  The next day the rash was 5 inches in diameter and hot to the touch.  Patient saw doctor and was prescribed cephalexin 500mg BID for ten days.  Rash cleared by end of treatment.
severe soreness in both arms (6:00 evening)  then broke out in itchy hives on knees, waist, stomach, upper arms, back,  and hand (starting slowly at 9:00 pm).  severe soreness in both legs - felt paralyzed (10:00 pm in bed).  March 23, soreness in legs gone and right arm less sore, but left arm still sore.  Broke out in  itchy hives on both face cheeks (9:00 am).  Used Cordizon 10 to lessen itch on the areas I could reach all through the day. called doctor and got an appointment March 23 at 3:10.
sore left arm, little bit swollen; sore left arm, little bit swollen; covid vaccine in the bicep area/vaccine very low in the arm (into the bicep) and not the deltoid; This is a spontaneous report from a contactable other hcp (Nurse). A 76-years-old male patient received bnt162b2 (BNT162B2), dose 2 intramuscular, administered in Arm on an unspecified date (Batch/Lot Number: EM9809) as 0.3 mL, single for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient previously received first dose of bnt162b2 (Lot: EL3249) via intramuscular in left deltoid on 18Jan2021, unknown time as single dose for covid-19 immunisation. On 08Feb2021, covid vaccine was administered in the bicep area/vaccine very low in the arm (into the bicep) and not the deltoid and on 09Feb2021, sore left arm, little bit swollen. Clinical course of the events includes, someone at a vaccine clinic, the second dose of the covid vaccine was administered very low in the arm. States the injection probably did not go into the deltoid, probably went in the bicep. She is asking if the injection would need to be repeated. She wants to know if the vaccines will need to be repeated. She also had a sore left arm and it was little bit swollen which started on the morning of 09Feb2021. The outcome for the event covid vaccine in the bicep area/vaccine very low in the arm (into the bicep) and not the deltoid was unknown and for the events sore left arm, little bit swollen was not recovered.
Date of Admission  12/31/2021   Date of Discharge  01/01/2022   Reason for Hospitalization   exposed to covid, having symptoms of chills, sovb, cough and nausea for 3 days.  Hospital Course    Patient is a 55-year-old female with medical history significant for hypertension who presented to the ER with chief complaints of lightheadedness and shortness of breath. Patient tested positive for COVID19 on 12/31/2021 and was started on dexamethasone and remdesivir. We are monitoring her oxygen status and weaning it as tolerated. [1]   her condition improved overnight. Home oxygen evaluation was reassuring for no oxygen needed. patient will be discharged to complete 10 days of Decadron. instructed to come back if her symptoms gt worse  Discharge Diagnoses      1. Flu-like symptoms     2. COVID-19     3. Acute hypoxemic respiratory failure     Other Diagnoses   Ongoing  BMI 34.0-34.9,adult  Hypertension  Obesity  Vapes nicotine containing substance  Historical  No qualifying data        Discharge Disposition  home  Medications  New, Changed, or Refilled Medications  None    Medications to be Continued  aspirin (aspirin 81 mg , chewable) 81 mg, 1 Tablet(s), Daily, 0 Refill(s)    azithromycin 0 Refill(s) Comments: to finish january 2 , 2022   diltiazem (dilTIAZem (Eqv-Cardizem CD) 360 mg/24 hours , extended release) 360 mg, 1 capsule(s), Oral, Daily, 0 Refill(s)    hydroCHLOROthiazide (hydroCHLOROthiazide 25 mg) 25 mg, 1 Tablet(s), Oral, Daily, 0 Refill(s)    losartan (losartan 100 mg) 100 mg, 1 Tablet(s), Oral, Daily, 0 Refill(s)      Discontinued Medications  None  Physical Exam at Discharge  Vitals & Measurements  T: 36.4 °C  TMIN: 36.3 °C  TMAX: 36.8 °C  HR: 59  RR: 18  BP: 135/80  SpO2: 94%  WT: 101 kg  BMI: 34.9      General: Alert and appropriate Respiratory: Clear to auscultation bilaterally Cardiovascular: Normal Heart sounds, Regular rate/rhythm.No edema. Gastrointestinal: Soft, Non-distended, no organomegaly Musculoskeletal: Normal range of motion, No tenderness, No swelling Integumentary: Warm, Intact Neurologic: Awake, alert, oriented to time, place and person. No focal deficits Psychiatric: Cooperative, Appropriate mood & affect  Time Spent  I personally spent 31 minutes coordinating discharge including final face to face visit with patient and family, discharge medication reconciliation, instructions for continuing care and discharge summary        Nursing/Other Orders   Regular Diet. Ordered on 12/31/21 19:03:00 CST, Meal Start Time Supper 1615 to 1745   Intake and Output. 12/31/21 16:30:29 CST, Continuous Order, q12h. Order comment: Ordered by system rule: ORD_ADD_CHF_TASKS based on indications for congestive heart failure.   Intake and Output. 12/31/21 19:03:00 CST, Continuous Order   Activity As Tolerated. 12/31/21 19:03:00 CST, Continuous Order, activity as tolerated with patient confined to room.   Code Status. Code Status Description: Full Code    [1] Admission H & P;  12/31/2021 18:02 CST
Fever; Chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills) and PAIN (Body aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O11J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Dec-2020, the patient experienced PYREXIA (Fever), CHILLS (Chills) and PAIN (Body aches). At the time of the report, PYREXIA (Fever), CHILLS (Chills) and PAIN (Body aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Treatment for reported events included acetaminophen (Tylenol) and Ibuprofen.        Most recent FOLLOW-UP information incorporated above includes: On 24-Mar-2021: No new information was provided.; Reporter's Comments: This case concerns a male subject of unknown age, who experienced a non-serious expected events of fever and chills and non-serious unexpected event of body pain. All events occurred one day after after first dose of mRNA-1273 vaccine. Treatment for reported events included Tylenol and Ibuprofen, however outcome was reported as unknown.
Crying, dizziness, nausea, chills, arm pain, stiffness, whole
Pt c/o feeling "sweaty" 15 mins after receiving 1st dose of the vaccine. She denied any medical hx or allergies. She was assessed and monitored by NP, EMT, and paramedic. BP - 100/70, HR - 89, resp - 16, 02 sat - 95% on RA. Repeated BP - 110/70.
This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient. A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 22Dec2020 (Lot number: EK5730) at the age of 46 years as dose 1, single for Covid-19 immunisation. Relevant medical history included: "Insulin resistance" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing). Concomitant medication(s) included: Metformin; Tirosint; Cytomel. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE WARMTH (non-serious), outcome "recovered" and all described as "On dose 1 of Pfizer Covid vaccine, saw a much smaller red warm spot about quarter to half dollar in size". Additional information: On dose 1 of Pfizer Covid vaccine, saw a much smaller red warm spot about quarter to half dollar in size but not raised and only lasted about 1 week. No Covid prior vaccination and not tested for Covid post vaccination. No known allergies. Follow-up attempts are completed. No further information is expected.
On Tuesday, Sept 29,2009 my daughter was administered the Dtap vaccine by her pediatrician.  later that day, she complained that her arm was very sore,  a typical reaction.  the next day, Sept 30th her arm swelled to the size of a tennis ball at the site.  the whole area was red and very hot to the touch.  i immediately called the doctor's office to report the problem and to ask what needs to be done.  3 hours later, my call was returned.  the doctor advised putting a warm compress on the area.  my daughter said the cloth didn't feel warm, it felt cool, because her arm was so hot.  the doctor also said to come in the next morning if the symptoms had not subsided.  the next morning it had not subsided and I took her to the doctor's office.  the doctor who administered the vaccine originally looked at my daughter's arm, said it was typical reaction and to put cool compresses on it.  first of all, I did not find in researching that such extensive swelling, redness with heat at the site were typical reactions and second, the treatment recommendations from two doctors from the same practice were unacceptably diverse.  my daughter seems to be fine today although the site is still swollen three days after administration of the vaccine. unsure of any long term affects at this point.
according to mom @ clinic visit 16AUG95 pt was seen @ hosp ER p/last vax; had fever & screaming; record from ER stated parents said pt had fever since vax; pt was weak & had cough; hosp dx URI; t99
Went to ER twice after first shot. Blood work from physical came back unnormal. High elevations in platelet, liver, and kidney. Very sick for 3 weeks. 2nd shot: woke up next day ended in ER with fever over 102. Continuous pain, nausea, anxiety, and migraines. PCP and doctors keep denying the shot caused the issues and urged me to get the 2nd dose.
Narrative:  60-year old male with PMHx significant for back pain, admitted on 5/26/2021 for complaint of progressive weakness and numbness along his entire body. Per documentation, he had his second COVID-19 vaccine on 05/14.Two days later, he started having watery explosive diarrhea. One week later, he started having numbness, tingling, bowel and bladder incontinence. A gradually progressed to his hands and torso. The day before admission on 05/26, he had difficulty swallowing. Speech consult determined that he should be NPO with NG tube feedings. He had been to the ED multiple times before admission which did MRI of his back that showed right neural foraminal stenosis at L5/S1. He was transferred to different facility after receiving steroids for back pain. Patient was admitted on medical service in ICU. He was closely monitored due to worsening of respiratory status and muscle weakness patient was intubated. Neurology was also consulted. Patient was treated with 5 days course of IVIG. Did not require plasmapheresis. Patient also required PEG tube placement. After starting the tube feeding he also developed abdominal distension and ileus. Therefore PEG tube is on hold. Seen by general surgery and recommended good bowel bowel regimen. Patient was clinically treated for Guillain-Barre syndrome per neurology recommendations. Lumbar puncture was not done because of his body habitus was not safe to do LP. I discussed with Neurology today. And recommended to have outpatient follow-up with Neurology. He will be discharged to long-term rehab while remaining on ventilator.
No adverse effects reported; the patient received a dose of VARIVAX via the intramuscular route; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. Concomitant therapy included sterile diluent (STERILE DILUENT). No information regarding the patient's pertinent medical history and drug reactions or allergies was provided. On 29-AUG-2019, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck)(VARIVAX) intramuscularly (lot # R035223, expiry date 04-DEC-2020) (exact dose was not reported) for prophylaxis.  No adverse effects were reported. The outcome of inappropriate route of vaccination and no adverse effects was unknown.
This spontaneous report as received from a nurse via company representative refers to a patient of unspecified demographics. On 22-JAN-2008, the patient was vaccinated with ZOSTAVAX, dose, frequency was unspecified. Concomitant medication was unspecified. Approximately on an unknown date in 2014 (reported as recently), the patient was recently seen in the office and had developed shingles. No product quality complaint was involved. The outcome of event shingles was unknown. The reporters causality for the event shingles with the therapy of ZOSTAVAX was not reported. No further information was provided. Additional information has been requested.
I am not feeling well; had a Covid PCR done swapped on yesterday and I am Covid positive; had a Covid PCR done swapped on yesterday and I am Covid positive; This is a spontaneous report from a contactable nurse. This nurse reported for herself that the 35-year-old female patient who received bnt162b2 (BNT162B2), via unknown route of administration on 23Dec2020 at single dose for covid-19 immunisation. Medical history was none. Concomitant medications were none. Nurse stated, "I received the Pfizer Vaccine this Wednesday and right before getting the vaccine, I had a Covid test (captured as per verbatim) on before the vaccine on Tuesday (22Dec2020) was negative. I had a Covid PCR done swapped on yesterday (25Dec2020) and I am Covid positive. So I have the vaccine and I am Covid positive" Nurse stated "It's "140" "130" pounds (further bot clarified)." The patient was not feeling well. The outcome of the events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Based on the limited available information, the company considers that a causal relationship between the SARS-CoV-2 test positive and vaccination with BNT162B2 cannot be excluded.
Severe chills x 4 days. Temp for 2 1/2 days ranging from 99.1 to 102.0. Hot/hard lump on arm where recieved shot that was "size of a baseball. Flared up her arthritis.
pulmonary embolism; blood clot(s) in right leg from ankle to groin; This is a spontaneous report from a contactable consumer (patient).A patient of unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6204), via an unspecified route of administration on 26Mar2021, as single dose for covid-19 immunization. Medical history and concomitant medications were not reported. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6198), via an unspecified route of administration on 02Mar2021, as dose 1, single for covid-19 immunization and experienced swelling in my right thigh just above the knee. On 07May2021, after second dose, the patient experienced pulmonary embolism (hospitalization, medically significant) and blood clots in right leg from ankle to groin (hospitalization, medically significant). Discharge report stated no evidence of deep venous thrombosis. Outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
A customer came in for his covid booster and flu vaccine.  After one of our techs administered the vaccines, the patient passed out.  I was called into the room and immediately assisted the technician in tending to the customer.  After a few seconds he regained consciousness.  We gave him water and a wet towel to make him more comfortable.  The customer had indicated ?no? to ever having a adverse reaction to a vaccine before, including fainting or feeling dizzy on his VAR.  We asked if pt had previous reaction like this to a vaccine before  when he regained consciousness.  He then disclosed to us that he had a similar incident when he received a vaccination when he was a child.  After about 5 minutes of regaining consciousness, the customer fainted again.  We then proceeded to call an ambulance.  The paramedics arrived shortly after the call and proceeded to check his vitals.  During that time the customer fainted again for the 3rd time.  The paramedics hoisted the customer on to a gurney and transported the customer to the ER via ambulance.  The pt looked fine and alert when the paramedics took him away.
Red/swollen/itchy area at injection site - 11cm x 6.5 cm. Area is firm to touch and warmer than surrounding area. 25mg Benadryl po administered with instructions to continue Benadryl at home every 6 hours as needed.
4/7/22 PMH of depression and anxiety, presents to the emergency room with strange behavior, according to the family, and confusion.
Patient would stay up until 4 am in the morning go to sleep then wake up at 6 AM. This routine happened daily. Patient was speaking (words) then he regressed. He started babbling and crying.
DEVELOPED AN ERYTHEMATOUS SWOLLEN AREA OF CELLULITIS TO RIGHT DELTOID. TREATED WITH BENADRYL OVER 3 DAYS PERIOD, BACTRIM DS FOR BACTERIAL COVERAGE. WAS SENT TO ER 03/08/2016 AND WAS GIVEN MOTRIN.
I was experience mild spinning and dizziness off and on for a few weeks, so slight I didn't think much of it.  One night I woke up with full blown vertigo that persisted into the morning and kept me home from work.  I went to my doctor's office where the nurse practitioner diagnosed the vertigo, performed the epply maneuver and prescribed anti nausea medications.